| abstract |
In certain embodiments, the subject of the present invention is a method for treating protein folding disorders such as Alzheimer's disease, dementia, Parkinson's disease, Huntington's disease and prionic spongiform encephalopathy. The method comprises administering to a subject a compound of formula (I), wherein A and B are independently a monocyclic or bicyclic aromatic ring group or a heteroaromatic ring group. . In a preferred embodiment, the compound is a bis-indole compound. |